Probiotics Market in US 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	146 Pages	TechNavio	February, 2024	INF18690660

Best Price Guarantee
Price	from $2,500
Length	146 Pages
Publisher	TechNavio
Published Date	February, 2024
SKU	INF18690660

Probiotics Market In US 2024-2028

The probiotics market in US is forecasted to grow by USD 4.98 bn during 2023-2028, accelerating at a CAGR of 8.16% during the forecast period. The report on the probiotics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the health benefits of probiotics, expansion in the retail landscape, and increasing online sales of probiotics in US.

Technavio's probiotics market in US is segmented as below:

By Distribution Channel

Offline
Online

By End-user

Human probiotics
Animal probiotics

By Product

Probiotic functional food and beverage
Supplements
Animal feed

This study identifies the increasing application of probiotics in the cosmetic industry as one of the prime reasons driving the probiotics market in US growth during the next few years. Also, increasing M and A activities by vendors in the probiotics market and increasing the launch of new probiotics will lead to sizable demand in the market.

The report on the probiotics market in US covers the following areas:

Probiotics market in US sizing
Probiotics market in US forecast
Probiotics market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading probiotics market in US vendors that include BioGaia AB, Chr Hansen Holding AS, CUSTOM PROBIOTICS Inc., Danone, DuPont de Nemours Inc., General Mills Inc., InnovixLabs, Jarrow Formulas Inc., Koninklijke DSM NV, Lallemand Inc., Lifeway Foods Inc., Nestle SA, NOW Health Group Inc., Otsuka Holdings Co. Ltd., PepsiCo Inc., Reckitt Benckiser Group Plc, SFI Health, Swanson Health Products Inc., Symrise AG, The Procter and Gamble Co., Thorne HealthTech Inc., Twinlab Consolidated Holdings Inc., and Yakult Honsha Co. Ltd.. Also, the probiotics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Product; Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 08: Parent market; Exhibit 09: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 10: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 11: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%); Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Probiotics market in US 2018 - 2022; Exhibit 16: Historic Market Size - Data Table on probiotics market in US 2018 - 2022 ($ billion); 4.2 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 End-user Segment Analysis 2018 - 2022; Exhibit 18: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.4 Product Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 20: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 27: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 28: Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Exhibit 29: Chart on Comparison by Distribution Channel; Exhibit 30: Data Table on Comparison by Distribution Channel; 6.3 Offline - Market size and forecast 2023-2028; Exhibit 31: Chart on Offline - Market size and forecast 2023-2028 ($ billion); Exhibit 32: Data Table on Offline - Market size and forecast 2023-2028 ($ billion); Exhibit 33: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibit 34: Data Table on Offline - Year-over-year growth 2023-2028 (%); 6.4 Online - Market size and forecast 2023-2028; Exhibit 35: Chart on Online - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Data Table on Online - Market size and forecast 2023-2028 ($ billion); Exhibit 37: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibit 38: Data Table on Online - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Distribution Channel; Exhibit 39: Market opportunity by Distribution Channel ($ billion); Exhibit 40: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 41: Chart on End-user - Market share 2023-2028 (%); Exhibit 42: Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Exhibit 43: Chart on Comparison by End-user; Exhibit 44: Data Table on Comparison by End-user; 7.3 Human probiotics - Market size and forecast 2023-2028; Exhibit 45: Chart on Human probiotics - Market size and forecast 2023-2028 ($ billion); Exhibit 46: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ billion); Exhibit 47: Chart on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibit 48: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%); 7.4 Animal probiotics - Market size and forecast 2023-2028; Exhibit 49: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ billion); Exhibit 50: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ billion); Exhibit 51: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibit 52: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by End-user; Exhibit 53: Market opportunity by End-user ($ billion); Exhibit 54: Data Table on Market opportunity by End-user ($ billion)
8 Market Segmentation by Product: 8.1 Market segments; Exhibit 55: Chart on Product - Market share 2023-2028 (%); Exhibit 56: Data Table on Product - Market share 2023-2028 (%); 8.2 Comparison by Product; Exhibit 57: Chart on Comparison by Product; Exhibit 58: Data Table on Comparison by Product; 8.3 Probiotic functional food and beverage - Market size and forecast 2023-2028; Exhibit 59: Chart on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion); Exhibit 60: Data Table on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion); Exhibit 61: Chart on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%); Exhibit 62: Data Table on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%); 8.4 Supplements - Market size and forecast 2023-2028; Exhibit 63: Chart on Supplements - Market size and forecast 2023-2028 ($ billion); Exhibit 64: Data Table on Supplements - Market size and forecast 2023-2028 ($ billion); Exhibit 65: Chart on Supplements - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on Supplements - Year-over-year growth 2023-2028 (%); 8.5 Animal feed - Market size and forecast 2023-2028; Exhibit 67: Chart on Animal feed - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on Animal feed - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on Animal feed - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on Animal feed - Year-over-year growth 2023-2028 (%); 8.6 Market opportunity by Product; Exhibit 71: Market opportunity by Product ($ billion); Exhibit 72: Data Table on Market opportunity by Product ($ billion)
9 Customer Landscape: 9.1 Customer landscape overview; Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 74: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 75: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 76: Overview on factors of disruption; 11.4 Industry risks; Exhibit 77: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 78: Vendors covered; 12.2 Market positioning of vendors; Exhibit 79: Matrix on vendor position and classification; 12.3 BioGaia AB; Exhibit 80: BioGaia AB - Overview; Exhibit 81: BioGaia AB - Business segments; Exhibit 82: BioGaia AB - Key news; Exhibit 83: BioGaia AB - Key offerings; Exhibit 84: BioGaia AB - Segment focus; 12.4 Chr Hansen Holding AS; Exhibit 85: Chr Hansen Holding AS - Overview; Exhibit 86: Chr Hansen Holding AS - Business segments; Exhibit 87: Chr Hansen Holding AS - Key news; Exhibit 88: Chr Hansen Holding AS - Key offerings; Exhibit 89: Chr Hansen Holding AS - Segment focus; 12.5 Danone; Exhibit 90: Danone - Overview; Exhibit 91: Danone - Business segments; Exhibit 92: Danone - Key news; Exhibit 93: Danone - Key offerings; Exhibit 94: Danone - Segment focus; 12.6 DuPont de Nemours Inc.; Exhibit 95: DuPont de Nemours Inc. - Overview; Exhibit 96: DuPont de Nemours Inc. - Business segments; Exhibit 97: DuPont de Nemours Inc. - Key news; Exhibit 98: DuPont de Nemours Inc. - Key offerings; Exhibit 99: DuPont de Nemours Inc. - Segment focus; 12.7 Koninklijke DSM NV; Exhibit 100: Koninklijke DSM NV - Overview; Exhibit 101: Koninklijke DSM NV - Business segments; Exhibit 102: Koninklijke DSM NV - Key news; Exhibit 103: Koninklijke DSM NV - Key offerings; Exhibit 104: Koninklijke DSM NV - Segment focus; 12.8 Lallemand Inc.; Exhibit 105: Lallemand Inc. - Overview; Exhibit 106: Lallemand Inc. - Product / Service; Exhibit 107: Lallemand Inc. - Key offerings; 12.9 Lifeway Foods Inc.; Exhibit 108: Lifeway Foods Inc. - Overview; Exhibit 109: Lifeway Foods Inc. - Product / Service; Exhibit 110: Lifeway Foods Inc. - Key offerings; 12.10 Nestle SA; Exhibit 111: Nestle SA - Overview; Exhibit 112: Nestle SA - Business segments; Exhibit 113: Nestle SA - Key news; Exhibit 114: Nestle SA - Key offerings; Exhibit 115: Nestle SA - Segment focus; 12.11 NOW Health Group Inc.; Exhibit 116: NOW Health Group Inc. - Overview; Exhibit 117: NOW Health Group Inc. - Product / Service; Exhibit 118: NOW Health Group Inc. - Key offerings; 12.12 Otsuka Holdings Co. Ltd.; Exhibit 119: Otsuka Holdings Co. Ltd. - Overview; Exhibit 120: Otsuka Holdings Co. Ltd. - Business segments; Exhibit 121: Otsuka Holdings Co. Ltd. - Key offerings; Exhibit 122: Otsuka Holdings Co. Ltd. - Segment focus; 12.13 PepsiCo Inc.; Exhibit 123: PepsiCo Inc. - Overview; Exhibit 124: PepsiCo Inc. - Business segments; Exhibit 125: PepsiCo Inc. - Key news; Exhibit 126: PepsiCo Inc. - Key offerings; Exhibit 127: PepsiCo Inc. - Segment focus; 12.14 Reckitt Benckiser Group Plc; Exhibit 128: Reckitt Benckiser Group Plc - Overview; Exhibit 129: Reckitt Benckiser Group Plc - Business segments; Exhibit 130: Reckitt Benckiser Group Plc - Key offerings; Exhibit 131: Reckitt Benckiser Group Plc - Segment focus; 12.15 Symrise AG; Exhibit 132: Symrise AG - Overview; Exhibit 133: Symrise AG - Business segments; Exhibit 134: Symrise AG - Key offerings; Exhibit 135: Symrise AG - Segment focus; 12.16 The Procter and Gamble Co.; Exhibit 136: The Procter and Gamble Co. - Overview; Exhibit 137: The Procter and Gamble Co. - Business segments; Exhibit 138: The Procter and Gamble Co. - Key news; Exhibit 139: The Procter and Gamble Co. - Key offerings; Exhibit 140: The Procter and Gamble Co. - Segment focus; 12.17 Yakult Honsha Co. Ltd.; Exhibit 141: Yakult Honsha Co. Ltd. - Overview; Exhibit 142: Yakult Honsha Co. Ltd. - Business segments; Exhibit 143: Yakult Honsha Co. Ltd. - Key offerings; Exhibit 144: Yakult Honsha Co. Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 145: Inclusions checklist; Exhibit 146: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 147: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 148: Research methodology; Exhibit 149: Validation techniques employed for market sizing; Exhibit 150: Information sources; 13.5 List of abbreviations; Exhibit 151: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Vendor Market Positioning; Exhibits8: Parent market; Exhibits9: Market Characteristics; Exhibits10: Offerings of vendors included in the market definition; Exhibits11: Market segments; Exhibits12: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits13: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits14: Chart on US: Year-over-year growth 2023-2028 (%); Exhibits15: Data Table on US: Year-over-year growth 2023-2028 (%); Exhibits16: Historic Market Size - Data Table on probiotics market in US 2018 - 2022 ($ billion); Exhibits17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits18: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits28: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by Distribution Channel; Exhibits30: Data Table on Comparison by Distribution Channel; Exhibits31: Chart on Offline - Market size and forecast 2023-2028 ($ billion); Exhibits32: Data Table on Offline - Market size and forecast 2023-2028 ($ billion); Exhibits33: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on Offline - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Online - Market size and forecast 2023-2028 ($ billion); Exhibits36: Data Table on Online - Market size and forecast 2023-2028 ($ billion); Exhibits37: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits39: Market opportunity by Distribution Channel ($ billion); Exhibits40: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits41: Chart on End-user - Market share 2023-2028 (%); Exhibits42: Data Table on End-user - Market share 2023-2028 (%); Exhibits43: Chart on Comparison by End-user; Exhibits44: Data Table on Comparison by End-user; Exhibits45: Chart on Human probiotics - Market size and forecast 2023-2028 ($ billion); Exhibits46: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ billion); Exhibits47: Chart on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ billion); Exhibits50: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ billion); Exhibits51: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibits53: Market opportunity by End-user ($ billion); Exhibits54: Data Table on Market opportunity by End-user ($ billion); Exhibits55: Chart on Product - Market share 2023-2028 (%); Exhibits56: Data Table on Product - Market share 2023-2028 (%); Exhibits57: Chart on Comparison by Product; Exhibits58: Data Table on Comparison by Product; Exhibits59: Chart on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion); Exhibits60: Data Table on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion); Exhibits61: Chart on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%); Exhibits62: Data Table on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%); Exhibits63: Chart on Supplements - Market size and forecast 2023-2028 ($ billion); Exhibits64: Data Table on Supplements - Market size and forecast 2023-2028 ($ billion); Exhibits65: Chart on Supplements - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Supplements - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Animal feed - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on Animal feed - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on Animal feed - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Animal feed - Year-over-year growth 2023-2028 (%); Exhibits71: Market opportunity by Product ($ billion); Exhibits72: Data Table on Market opportunity by Product ($ billion); Exhibits73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits74: Impact of drivers and challenges in 2023 and 2028; Exhibits75: Overview on Criticality of inputs and Factors of differentiation; Exhibits76: Overview on factors of disruption; Exhibits77: Impact of key risks on business; Exhibits78: Vendors covered; Exhibits79: Matrix on vendor position and classification; Exhibits80: BioGaia AB - Overview; Exhibits81: BioGaia AB - Business segments; Exhibits82: BioGaia AB - Key news; Exhibits83: BioGaia AB - Key offerings; Exhibits84: BioGaia AB - Segment focus; Exhibits85: Chr Hansen Holding AS - Overview; Exhibits86: Chr Hansen Holding AS - Business segments; Exhibits87: Chr Hansen Holding AS - Key news; Exhibits88: Chr Hansen Holding AS - Key offerings; Exhibits89: Chr Hansen Holding AS - Segment focus; Exhibits90: Danone - Overview; Exhibits91: Danone - Business segments; Exhibits92: Danone - Key news; Exhibits93: Danone - Key offerings; Exhibits94: Danone - Segment focus; Exhibits95: DuPont de Nemours Inc. - Overview; Exhibits96: DuPont de Nemours Inc. - Business segments; Exhibits97: DuPont de Nemours Inc. - Key news; Exhibits98: DuPont de Nemours Inc. - Key offerings; Exhibits99: DuPont de Nemours Inc. - Segment focus; Exhibits100: Koninklijke DSM NV - Overview; Exhibits101: Koninklijke DSM NV - Business segments; Exhibits102: Koninklijke DSM NV - Key news; Exhibits103: Koninklijke DSM NV - Key offerings; Exhibits104: Koninklijke DSM NV - Segment focus; Exhibits105: Lallemand Inc. - Overview; Exhibits106: Lallemand Inc. - Product / Service; Exhibits107: Lallemand Inc. - Key offerings; Exhibits108: Lifeway Foods Inc. - Overview; Exhibits109: Lifeway Foods Inc. - Product / Service; Exhibits110: Lifeway Foods Inc. - Key offerings; Exhibits111: Nestle SA - Overview; Exhibits112: Nestle SA - Business segments; Exhibits113: Nestle SA - Key news; Exhibits114: Nestle SA - Key offerings; Exhibits115: Nestle SA - Segment focus; Exhibits116: NOW Health Group Inc. - Overview; Exhibits117: NOW Health Group Inc. - Product / Service; Exhibits118: NOW Health Group Inc. - Key offerings; Exhibits119: Otsuka Holdings Co. Ltd. - Overview; Exhibits120: Otsuka Holdings Co. Ltd. - Business segments; Exhibits121: Otsuka Holdings Co. Ltd. - Key offerings; Exhibits122: Otsuka Holdings Co. Ltd. - Segment focus; Exhibits123: PepsiCo Inc. - Overview; Exhibits124: PepsiCo Inc. - Business segments; Exhibits125: PepsiCo Inc. - Key news; Exhibits126: PepsiCo Inc. - Key offerings; Exhibits127: PepsiCo Inc. - Segment focus; Exhibits128: Reckitt Benckiser Group Plc - Overview; Exhibits129: Reckitt Benckiser Group Plc - Business segments; Exhibits130: Reckitt Benckiser Group Plc - Key offerings; Exhibits131: Reckitt Benckiser Group Plc - Segment focus; Exhibits132: Symrise AG - Overview; Exhibits133: Symrise AG - Business segments; Exhibits134: Symrise AG - Key offerings; Exhibits135: Symrise AG - Segment focus; Exhibits136: The Procter and Gamble Co. - Overview; Exhibits137: The Procter and Gamble Co. - Business segments; Exhibits138: The Procter and Gamble Co. - Key news; Exhibits139: The Procter and Gamble Co. - Key offerings; Exhibits140: The Procter and Gamble Co. - Segment focus; Exhibits141: Yakult Honsha Co. Ltd. - Overview; Exhibits142: Yakult Honsha Co. Ltd. - Business segments; Exhibits143: Yakult Honsha Co. Ltd. - Key offerings; Exhibits144: Yakult Honsha Co. Ltd. - Segment focus; Exhibits145: Inclusions checklist; Exhibits146: Exclusions checklist; Exhibits147: Currency conversion rates for US$; Exhibits148: Research methodology; Exhibits149: Validation techniques employed for market sizing; Exhibits150: Information sources; Exhibits151: List of abbreviations